If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

Share Price is delayed by 15 minutes
Get Live Data
14,270.00    -285.00 (-1.96%)
Bid:
14,305.00
Ask:
14,315.00
Spread: 10.00 (0.07%)
Market Cap: £16.29b
NXT Live PriceLast checked at - London Stock Exchange

Intraday Next Share Chart

Director/PDMR Shareholding

17 Oct 2025 15:36

RNS Number : 8982D
Next PLC
17 October 2025
 

17 October 2025

NEXT plc

Notification of Transactions by Persons Discharging Managerial Responsibility (PDMR) and Person Closely Associated (PCA) with them

The following notification is made under article 19 of the UK Market Abuse Regulation. On 17 October 2025 the following share options were granted to certain PDMRs/PCAs under the NEXT plc 2020 Sharesave Plan. The exercise price of £95.28 was set in accordance with HMRC rules for sharesave plans.

Each PDMR/PCA has elected for a plan term of three years. The Sharesave contracts will commence on 1 December 2025 and, subject to the rules of the Plan, the options will be exercisable for the period of six months following the maturity date of 1 December 2028.

1

 

Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")

 

a)

 

Name

 

1. Jeremy Stakol

2. Marcelle Stakol

3. Sebastian Shields

 

2

 

Reason for the notification

a)

 

Position/status

 

1. Group Investments, Acquisitions and Third Party Brands Director (PDMR)

2. Lipsy Brand Director (PCA with Jeremy Stakol)

3. UX/UI Designer (PCA with Jane Shields)

 

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

NEXT plc

b)

 

LEI

 

213800WQD8ECPZP9PH98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

 

 

 

Description of the financial instrument, type of instrument

 

Identification code

Sharesave options over ordinary shares of £0.10 each

 

GB0032089863

b)

Nature of the transaction

 

Grant of options under the NEXT plc 2020 Sharesave Plan over the following number of Shares:

1. Jeremy Stakol - 76

2. Marcelle Stakol - 76

3. Sebastian Shields - 95

c)

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

Jeremy Stakol

£95.28

76

Marcelle Stakol

£95.28

76

Sebastian Shields

£95.28

95

d)

Aggregated information

- Aggregated volume

- Price

 

 

n/a

n/a

e)

Date of the transaction(s)

 

17 October 2025

f)

Place of transaction

 

Outside a trading venue

 

H Woodall-Pagan

Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVSIELDLIE
Date   Source Headline
6th May 20217:00 amRNSTrading Statement
4th May 20215:28 pmRNSTotal Voting Rights
20th Apr 202111:24 amRNSAnnual Financial Report
7th Apr 20214:38 pmRNSDirector/PDMR Shareholding
7th Apr 20214:37 pmRNSDirector/PDMR Shareholding
6th Apr 20214:31 pmRNSDirector/PDMR Shareholding
1st Apr 202110:47 amRNSTotal Voting Rights
1st Apr 20217:00 amRNSNEXT PLC-Results for the Year Ending January 2021
24th Mar 20216:10 pmRNSHolding(s) in Company
10th Mar 202111:00 amRNSNEXT PLC - Acquisition of an Interest in Reiss
1st Mar 20219:00 amRNSTotal Voting Rights
1st Feb 20219:37 amRNSTotal Voting Rights
25th Jan 202112:59 pmRNSBlock listing Interim Review
20th Jan 202110:11 amRNSDirector/PDMR Shareholding
19th Jan 20218:51 amRNSChange in External Directorships
11th Jan 20213:53 pmRNSHolding(s) in Company
5th Jan 20214:55 pmRNSDirector/PDMR Shareholding
5th Jan 20217:00 amRNSNEXT PLC - Trading Statement
4th Jan 20219:25 amRNSTotal Voting Rights
8th Dec 20201:20 pmRNSHolding(s) in Company
1st Dec 20201:53 pmRNSTotal Voting Rights
17th Nov 20205:39 pmRNSDirector/PDMR Shareholding
16th Nov 20209:50 amRNSHolding(s) in Company
12th Nov 20205:52 pmRNSDirector/PDMR Shareholding
2nd Nov 202011:00 amRNSTotal Voting Rights
28th Oct 20202:59 pmRNSDirector/PDMR Shareholding
28th Oct 20207:00 amRNSTrading Statement
19th Oct 20204:00 pmRNSHolding(s) in Company
1st Oct 20209:26 amRNSTotal Voting Rights
25th Sep 20205:20 pmRNSReplacement:Results for Half Year Ending July 2020
21st Sep 20205:20 pmRNSDirector/PDMR Shareholding
21st Sep 20205:14 pmRNSDirector/PDMR Shareholding
18th Sep 20203:02 pmRNSDirector/PDMR Shareholding
17th Sep 20207:00 amRNSResults for the Half Year Ending July 2020
1st Sep 20201:38 pmRNSTotal Voting Rights
3rd Aug 20202:41 pmRNSTotal Voting Rights
29th Jul 20207:00 amRNSTrading Statement
24th Jul 20202:25 pmRNSBlock listing Interim Review
13th Jul 20201:07 pmRNSDirectorate Change
3rd Jul 20204:37 pmRNSHolding(s) in Company
1st Jul 20203:25 pmRNSTotal Voting Rights
1st Jun 20209:47 amRNSTotal Voting Rights
14th May 202012:30 pmRNSResult of AGM
1st May 20209:01 amRNSTotal Voting Rights
29th Apr 20207:00 amRNSTrading Statement
27th Apr 202010:55 amRNSDisclosure of Rights Attaching to Equity Shares
14th Apr 20204:40 pmRNSAnnual Financial Report
14th Apr 20207:00 amRNSNEXT Reopens Online, Warehousing and Distribution
8th Apr 20205:10 pmRNSDirector/PDMR Shareholding
3rd Apr 20206:03 pmRNSCovid Corporate Financing Facility (CCFF)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.